Leader Of Vero Beach Clandestine Methamphetamine Lab Sentenced To 20 Years In Prison
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Leader Of Vero Beach Clandestine Methamphetamine Lab Sentenced To 20 Years In Prison

Leader Of Vero Beach Clandestine Methamphetamine Lab Sentenced To 20 Years In Prison

December 18, 2013
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 362-3364 - Option 5

MIAMI - Mark R. Trouville, Special Agent in Charge, U.S. Drug Enforcement (DEA), Miami Field Division, Wifredo A. Ferrer, United States Attorney for the Southern District of Florida, and Deryl Loar, Sheriff, Indian River County Sheriff's Office, announce the sentencing of four Vero Beach residents for their participation in a Vero Beach clandestine methamphetamine lab: Edward McElhenny, 50, Clinton Story, 30, Paul Richardson, 27, and Kelly McCartney, 36.
 
Edward McElhenny was sentenced to 20 years in prison, followed by four years of supervised release concurrently on two counts. He pleaded guilty on October 7, 2013 to a superseding information charging him with conspiracy to manufacture, distribute and possess with intent to distribute a controlled substance, over five grams of methamphetamine, in violation of Title 21, United States Code, Section 846. He also pleaded guilty to maintaining a place for the purpose of manufacturing and distributing methamphetamine, in violation of Title 21, United States Code, Sections 856(a)(1) and 2.
 
Clint Story was sentenced to 66 months in prison, followed by three years of supervised release, concurrently on two counts. He pleaded guilty on September 26, 2013 to manufacturing, distributing and possessing with intent to distribute methamphetamine, in violation of Title 21, United States Code, Sections 841(a)(1) and 2.  Story also pleaded guilty to maintaining a place for the purpose of manufacturing and distributing methamphetamine, in violation of Title 21, United States Code, Sections 856(a)(1) and 2.
 
Paul Richardson was sentenced to 24 months in prison, followed by three years of supervised release. He pleaded guilty on September 20, 2013 to manufacturing, distributing and possessing with intent to distribute methamphetamine, in violation of Title 21, United States Code, Sections 841(a)(1) and 2.
 
Kelly McCartney was sentenced to 18 months in prison, followed by two years of supervised release. She pleaded guilty on September 20, 2013 to manufacturing, distributing and possessing with intent to distribute methamphetamine, in violation of Title 21, United States Code, Sections 841(a)(1) and 2.
 
All four defendants were required to pay restitution to the DEA for clean-up of the clandestine lab.
 
According to the criminal complaint, during the third week of April 2013, the Indian River County Sheriff's (IRCSO), Multi-Agency Criminal (MACE) Unit conducted an investigation, which led to the execution of a search warrant. On May 9, 2013, members of the DEA-Clandestine Laboratory Enforcement (CLET) executed a state search warrant at the residence of Clint and Angela Story, after a confidential informant purchased methamphetamine from Clint Story at his residence. At the time of entry, Clinton Story, Edward McElhenny, Paul Richardson and Angela Story were at the residence and were detained. Clinton Story, Angela Story, and Paul Richardson all admitted to purchasing pseudoephedrine, knowing it was for the manufacture of methamphetamine. 
 
Edward McElhenny admitted that he manufactured methamphetamine in the past. The DEA CLET team members searched the home and surrounding property. A search of the residence led to the discovery of pre-cursor chemicals and laboratory equipment which were utilized in and comprised a fully operational methamphetamine laboratory. A fingerprint specialist processed the scene and physical evidence, and discovered the fingerprints of Clinton Story, Edward McElhenny, and Kelly Maureen McCartney. McCartney admitted that she visited Clint and Angela Story's residence on multiple occasions, and was aware of the methamphetamine manufacturing and use that took place at the residence. She also acknowledged that she purchased pseudoephedrine packets on multiple occasions with the knowledge that it was being used to manufacture methamphetamine. 
 
At sentencing, the Court found that McElhenny was responsible for being an organizer or leader of criminal activity involving five or more participants, in that Clinton Story, Angela Story, Paul Richardson and Kelly McCartney all assisted him in the manufacture of methamphetamine, by purchasing the precursor chemical pseudoephedrine from area pharmacies, in an effort circumvent the laws restricting over the counter purchases. 
 
This investigation was conducted by the DEA and the Indian River County Sheriff's Office. The case was prosecuted by the United States Attorney's Office for the Southern District of Florida.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge - Miami
@deamiamidiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster